Your browser doesn't support javascript.
loading
Strategies for targeting cell surface proteins using multivalent conjugates and chemical biology.
Sachdev, Shivani; Cabalteja, Chino C; Cheloha, Ross W.
Afiliação
  • Sachdev S; National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK), Laboratory of Bioorganic Chemistry, Bethesda, MD, United States.
  • Cabalteja CC; National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK), Laboratory of Bioorganic Chemistry, Bethesda, MD, United States.
  • Cheloha RW; National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK), Laboratory of Bioorganic Chemistry, Bethesda, MD, United States. Electronic address: ross.cheloha@nih.gov.
Methods Cell Biol ; 166: 205-222, 2021.
Article em En | MEDLINE | ID: mdl-34752333
ABSTRACT
Proper function of receptors on the cell surface is essential for homeostasis. Compounds that target cell surface receptors to address dysregulation have proven exceptionally successful as therapeutic agents; however, the development of compounds with the desired specificity for receptors, cells, and tissues of choice has proven difficult in some cases. The use of compounds that can engage more than one binding site at the cell surface offers a path toward improving biological specificity or pharmacological properties. In this chapter we summarize historical context for the development of such bivalent compounds. We focus on developments in chemical methods and biological engineering to provide bivalent compounds in which the high affinity and specificity of antibodies are leveraged to create multifunctional conjugates with new and useful properties. The development of methods to meld biological macromolecules with synthetic compounds will facilitate modulation of receptor biology in ways not previously possible.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos Idioma: En Ano de publicação: 2021 Tipo de documento: Article